Navigating the Complexity of Non-Alcoholic Fatty Liver Disease

Authors: Hidig SM

DOI: 10.23880/ijsst-16000220

Volume 8, Issue 2

Abstract

Non-alcoholic fatty liver disease (NAFLD) has emerged as a significant public health concern, paralleling the global rise in obesity rates. It’s now recognized as the most common liver disorder worldwide, with an estimated prevalence of 20-30% among adults. Despite its prevalence, NAFLD’s clinical course and associated risks, particularly concerning the development of cirrhosis and hepatocellular carcinoma (HCC), have remained challenging to predict accurately. The recent study titled “Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease” offers valuable insights into the dynamic nature of fibrosis markers and their association with the progression of NAFLD-related complications

Keywords: Hepatocellular Carcinoma; Non-Alcoholic Fatty Liver Disease; Cirrhosis

View PDF